Xtant Medical Holdings Inc. (NYSE AMERICAN: XTNT)
$0.73
+0.0200 ( +2.82% ) 46.9K
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Market Data
Open
$0.73
Previous close
$0.71
Volume
46.9K
Market cap
$94.15M
Day range
$0.67 - $0.75
52 week range
$0.60 - $1.45
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 20 | Mar 07, 2024 |
4/a | Other | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Jan 18, 2024 |
4 | Insider transactions | 1 | Nov 17, 2023 |
10-q | Quarterly Reports | 90 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
8-k/a | 8K-related | 16 | Oct 26, 2023 |
8-k | 8K-related | 14 | Oct 23, 2023 |
4 | Insider transactions | 1 | Oct 17, 2023 |
8-k | 8K-related | 13 | Aug 18, 2023 |